Russell Investments Group
ADVM

Russell Investments Group’s Adverum Biotechnologies ADVM Stock Holding History

Russell Investments Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,375
Closed -$6.01K – 3842
2025
Q1 		$6.01K Buy
+1,375
New +$6.2K ﹤0.01% 3317
2024
Q4 		– Sell
-166
Closed -$1.17K – 3692
2024
Q3 		$1.17K Buy
+166
New +$1.21K ﹤0.01% 3466
2023
Q4 		– Sell
-1,600
Closed -$24K – 3201
2023
Q3 		$24K Buy
+1,600
New +$28.7K ﹤0.01% 2861
2022
Q2 		– Sell
-7,664
Closed -$100K – 2875
2022
Q1 		$100K Sell
7,664
-7,670
-50% -$112K ﹤0.01% 2562
2021
Q4 		$269K Sell
15,334
-7,145
-32% -$143K ﹤0.01% 2641
2021
Q3 		$487K Sell
22,479
-53
-0.2% -$1.35K ﹤0.01% 2471
2021
Q2 		$787K Buy
22,532
+14,509
+181% +$782K ﹤0.01% 2421
2021
Q1 		$790K Hold
8,023
– – ﹤0.01% 2340
2020
Q4 		$869K Sell
8,023
-3,763
-32% -$466K ﹤0.01% 2176
2020
Q3 		$1.21M Buy
11,786
+7,543
+178% +$1.13M ﹤0.01% 1974
2020
Q2 		$883K Buy
4,243
+1,262
+42% +$224K ﹤0.01% 2127
2020
Q1 		$291K Buy
+2,981
New +$348K ﹤0.01% 2410
2018
Q3 		– Sell
-2,070
Closed -$110K – 2941
2018
Q2 		$110K Sell
2,070
-200
-9% -$12K ﹤0.01% 2724
2018
Q1 		$132K Sell
2,270
-3,096
-58% -$193K ﹤0.01% 2716
2017
Q4 		$193K Sell
5,366
-1,234
-19% -$40.6K ﹤0.01% 2675
2017
Q3 		$241K Buy
+6,600
New +$183K ﹤0.01% 2632

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group's ADVM Position: Q2 2025 in Review

Russell Investments Group sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 1,375 shares — an estimated $6.01K sold.

Russell Investments Group first reported a position in ADVM in Q3 2017 and held it in 16 quarters. The position peaked at $1.21M in Q3 2020. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.

  • Russell Investments Group reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 1,375 Adverum Biotechnologies shares in Q2 2025, an estimated $6.01K.
  • Russell Investments Group first reported a position in Adverum Biotechnologies in Q3 2017 and held it in 16 quarters.
  • Russell Investments Group's Adverum Biotechnologies position peaked at $1.21M in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.